286 related articles for article (PubMed ID: 27324222)
21. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
22. The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.
Mestre L; Correa F; Docagne F; Clemente D; Guaza C
Biochem Pharmacol; 2006 Sep; 72(7):869-80. PubMed ID: 16914119
[TBL] [Abstract][Full Text] [Related]
23. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
[TBL] [Abstract][Full Text] [Related]
24. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B
Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
26. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
27. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
[TBL] [Abstract][Full Text] [Related]
28. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.
Pietrovito L; Iozzo M; Bacci M; Giannoni E; Chiarugi P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991773
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
30. The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.
Curran NM; Griffin BD; O'Toole D; Brady KJ; Fitzgerald SN; Moynagh PN
J Biol Chem; 2005 Oct; 280(43):35797-806. PubMed ID: 16105834
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
33. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
[TBL] [Abstract][Full Text] [Related]
35. WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals.
Xian X; Huang L; Zhang B; Wu C; Cui J; Wang Z
Cell Physiol Biochem; 2016; 39(6):2149-2157. PubMed ID: 27802436
[TBL] [Abstract][Full Text] [Related]
36. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats.
Mostafeezur RM; Zakir HM; Takatsuji H; Yamada Y; Yamamura K; Kitagawa J
PLoS One; 2012; 7(11):e50703. PubMed ID: 23209814
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
[TBL] [Abstract][Full Text] [Related]
40. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
